Design: open-label randomised controlled trial, Mann-Whitney U analysis, pain at seven time points as the primary outcome
Population: 217 patients scheduled for total knee arthroplasty
Primary outcome: numeric rating scale pain from recovery-room arrival through the afternoon of postoperative day 1
Effect: no difference at any time point (all P > .05); exploratory 48-hour oral morphine equivalent 70 mg (IQR 52.5–96.3) vs 96 mg (61.3–148.8), P = .008; median stay 1 vs 2 days, P < .001

The regional technique for total knee arthroplasty keeps acquiring targets, each added on plausibility rather than on a comparison. A randomised trial in 217 patients tested the accumulated version — adductor canal block, infiltration between popliteal artery and posterior capsule, genicular nerves, and blocks to the nerve to vastus medialis, vastus intermedius and the anterior femoral cutaneous nerve, using 40 mL of ropivacaine 5 mg/mL with 75 µg clonidine — against local infiltration analgesia with 150 mL of ropivacaine 2 mg/mL and adrenaline.

Pain did not differ at any of the seven measurement points, from recovery-room arrival to the afternoon of the first postoperative day. The median numeric rating scores tracked each other within half a point throughout. The exploratory secondary outcomes were another matter: 48-hour oral morphine equivalent consumption of 70 mg (interquartile range 52.5 to 96.3) against 96 mg (61.3 to 148.8), P = .008, and a median stay of one day against two, P < .001.

So the case for the eight-block technique is not comfort — it is opioid exposure and turnover, and it rests on secondary outcomes in a trial whose primary endpoint was negative and which was not blinded. Against that sit real costs: block time, ultrasound skill, and the additional risk of eight needle passes. If a unit wants to adopt it, the honest framing is a local trial with a pre-agreed audit of opioid consumption and objective discharge criteria, not a change made on the strength of these secondary findings.

Do not adopt the eight-block technique expecting better pain scores; there were none at any time point.
Local infiltration analgesia remains reasonable, particularly where block time or ultrasound expertise is limited.
Cost the extra theatre time and the eight needle passes before changing a pathway.
If you trial it, fix objective discharge criteria first — length of stay is the outcome expectation moves most.
Audit 48-hour opioid consumption locally rather than assuming the trial's difference transfers.

Why it matters

A technique built by accumulating targets did not outperform a single infiltration on the outcome patients report.

The statistics, in plain English

Seven primary comparisons, none significant, in a trial of 217 patients: this is a negative result rather than an underpowered one for the size of difference that would matter clinically. Once the primary endpoint fails, secondary outcomes lose their statistical protection — the P values of .008 and <.001 are descriptive, and the authors label these outcomes exploratory for that reason. The length-of-stay result is the most fragile: this was an open-label trial, everyone knew which technique had been used, and the decision to discharge is a human judgement.